KNG1 and lung adenocarcinoma: Furthermore, our findings failed to demonstrate a statistically significant relationship between bradykinin and the risk of lung adenocarcinoma (trait: finn-b-C3_NSCLC_ADENO) (OR, 1.321; 95% CI, 0.812–1.829; p = 0.283; SNPs = 14).